Calmodulin Potentiates RyR2 Block and Ca Wave Suppression by Flecainide  by Gomez-Hurtado, Nieves et al.
264a Monday, February 9, 20151333-Pos Board B284
Urocortin 2 Regulates Sarcoplasmic Reticulum Calcium via Phosphoryla-
tion of Phospholamban and SERCA Activation and Protects against Pro-
Arrhythmic Alternans in Cardiac Myocytes from Normal and Failing
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Stefanie Walther1, Joshua N. Edwards1, Joshua T. Maxwell1,
Florentina Pluteanu2, Susanne Renz3, Burkert Pieske4, Lothar A. Blatter1.
1Molecular Biophysics and Physiology, Rush University Medical Center,
Chicago, IL, USA, 2Institute for Pharmacology and Clinical Pharmacy,
Philipps-University of Marburg, Marburg, Germany, 3Cardiology and
Pneumologye, University Medicine Go¨ttingen, Go¨ttingen, Germany,
4Cardiology, Medical University of Graz, Graz, Austria.
We tested the effect of the cardioactive peptide Urocortin 2 (Ucn2; 100 nM)
on action potential (AP)-induced Ca transients (CaT), sarcoplasmic reticulum
(SR) Ca load and cardiac Ca alternans. Experiments were performed on single
rabbit atrial and ventricular myocytes from normal and failing hearts. Chronic
heart failure (HF) was induced by combined pressure- and volume-overload.
Ca and mechanical alternans was induced by electrical pacing. Changes in
cytosolic [Ca]i and [Ca]SR were monitored with fluorescent indicators, in
conjunction with sarcomere length measurements. The average Ca alternans
ratio (AR ¼ 1-S/L; S: small amplitude CaT; L: large-amplitude CaT) was
0.51 in normal atrial myocytes, and 0.43 and 0.53 in normal and HF ventric-
ular myocytes, respectively. Ucn2 increased SR Ca load in normal, and to a
larger degree in HF ventricular cells, and enhanced AP-induced SR Ca deple-
tion transients. Baseline phosphorylation levels of phospholamban (PLN) at
Ser16 were increased in HF myocytes, and Ucn2 stimulation further
augmented PLN phosphorylation in normal myocytes (~10-fold) and to a
lesser extent (~5-fold) in HF ventricular myocytes. Ucn2 completely abol-
ished Ca and mechanical alternans (within 2-3 min) in normal atrial as well
as in normal and HF ventricular myocytes. In the presence of Astressin-2B
(1 mM; inhibition of corticotropin-releasing factor receptor; CRFR2) and
H89 (1 mM; protein kinase A inhibition) Ucn2 failed to rescue alternans. In
conclusion, we propose that Ucn2 rescues cardiac alternans via CRFR2-
mediated stimulation of PKA, phosphorylation of PLN and enhanced cyto-
solic Ca sequestration by SERCA.
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Background: Loss of function mutations in hERG potassium channels underlie
the long QT syndrome type 2 (LQT2). LQT2 is associated with fatal ventricular
arrhythmias promoted by triggered activity in the form of early afterdepolari-
zations (EADs). However, the cellular mechanism of EAD formation remains
unexplored.
Methods: We have investigated the mechanism of EAD formation in LQT2
ventricular myocytes using a physiologically detailed computational model
of calcium (Ca2þ) cycling and membrane voltage dynamics. This model
bridges the submicron scale of individual couplons of plasmalemmal L-type
Ca2þ channels clusters and sarcoplasmic reticulum (SR) Ca2þ release units
(CRUs) and the whole cell. We incorporate the novel experimental finding
that ryanodine receptors (RyRs) Ca2þ release channels are remodeled in ven-
tricular mycoytes isolated from LQT2 transgenic rabbits; RyRs are hyper-
phosphorylated leading to enhanced channel activity and hence increased
Ca2þ leak.
Results: Computer simulations with RyR hyperactivity modeled as an
increased rate of channel opening show that hyperactivity is causally linked
to EAD formation. Under stimulation with the b-adrenergic agonist isoproter-
enol (ISO), LQT2myocytes with hyperactive RyRs exhibit EADs together with
decreased SR load and Ca2þ transient (CaT) amplitude, while myocytes with
normal RyR activity exhibit a prolonged action potential without reductions
of SR load and CaT amplitude. Simulations show that RyR hyperactivity
shortens RyR refractoriness at the CRU level, resulting in late aberrant Ca2þ
releases during repolarization. Those releases promote onset of EADs by
driving the forward mode Naþ-Ca2þ exchanger NCX1 current, which slows
repolarization and allows reactivation of L-type Ca2þ current. Modeling pre-
dictions are in good agreement with experimental observations, which show
that EADs in ISO-stimulated LQT2 myocytes are accompanied by late Ca2þ
releases together with decreased SR load and CaT amplitude, and that both
late releases and EADs are abolished by inhibition of CaMKII.1335-Pos Board B286
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Spontaneous calcium (Ca) release in cardiac myocytes can produce delayed
afterdepolarizations (DADs) that promote arrhythmias. In these studies, we
combined experimental and computational approaches to investigate quantita-
tively how Ca release features at subcellular, cellular, and tissue scales influ-
ence DADs. Spontaneous Ca release events and corresponding DADs were
measured experimentally from isolated rabbit ventricular myocytes exposed
to elevated extracellular Ca (2.7 mM) and isoproterenol (0.25 mM), and were
compared between lower and higher total intracellular Ca levels following 1
or 5 paced beats at 400 ms intervals, respectively. At the subcellular scale,
Ca waves emerged simultaneously from an average of 1.36 (low) and 2.5
(high) sites per Ca release event. Consistent with the criticality-based theory
of Ca wave emergence, Ca wave numbers were proportional to sarcoplasmic
reticulum (SR) Ca levels that produced INCX with 71.1 pA/pFms (low)
and 106.0 pA/pFms (high) integrated current densities upon rapid exposure
to caffeine (10 mM). At the cellular scale, whole-cell calcium transients had
peak amplitudes of 0.462 F/Fo (low) and 0.717 F/Fo (high) and full widths
at half maximum (FWHMs) of 309.0 ms (low) and 180.0 ms (high). Resultant
DADs had peak amplitudes of 1.41 mV (low) and 6.03 mV (high) and FWHMs
of 302.3 ms (low) and 140.3 ms (high). Ca wave latencies in single myocytes,
which determine Ca release synchrony in cardiac tissue, were 0.996 s (low) and
0.416 s (high). Computer simulation analyses implementing various combina-
tions of the experimentally measured factors suggest that greater numbers of Ca
waves, increased SR Ca release, and greater synchrony are associated with
larger DAD amplitudes in cardiac tissue. Simulations also suggest that the sub-
cellular number of Ca waves has the largest impact on DAD amplitude in
tissue.
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Using fluorescence resonance energy transfer (FRET), we directly tested the
hypothesis that S100A1 competes with calmodulin (CaM) for binding to
intact, functional ryanodine receptors type I (RyR1) and II (RyR2) from
skeletal and cardiac muscle, respectively. This hypothesis is largely based
on competition assays using isolated sarcoplasmic reticulum (SR) mem-
branes from skeletal muscle and evidence that S100A1 binds to peptides cor-
responding to one of the proposed CaM binding domains on RyR1.
However, competition between S100A1 and CaM for RyR binding has not
been directly detected. We targeted a donor-labeled FKBP12.6 (D-FKBP)
to the cytoplasmic domain of RyR1 or RyR2 in SR vesicles isolated from
pig skeletal or cardiac muscle. FRET was detected as a decrease of
D-FKBP fluorescence in the presence of 100nM acceptor-labeled CaM
(A-CaM) and used to index CaM binding to RyR. Upon pre-incubating SR
with [S100A1] ranging from 0.01 to >100 mM, we found partial inhibition
of FRET, with mM KI, for both skeletal and cardiac SR. By comparison,
FRET was completely inhibited by unlabeled WT-CaM (KI ~100nM), indi-
cating that A-CaM and WT-CaM bind RyR with similar affinities and at the
same site. Similar results were obtained using co-sedimentation assays con-
ducted under similar experimental conditions, to detect competition between
S100A1 and CaM binding to SR membranes. Taken together, these results
indicate that CaM-RyR binding may not be significantly competed by
S100A1 under normal physiologic conditions. Furthermore, structural anal-
ysis of FRET data suggests that S100A1 allosterically interacts with RyR-
CaM binding. Initial results from a complementary FRET approach, using
acceptor-labeled S100A1, further support the conclusion that S100A1 does
not significantly compete with CaM-RyR binding in skeletal or cardiac
muscle.
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classified as a class Ic antiarrhythmic agent, has been used to suppress ventric-
ular arrhythmias caused by spontaneous Ca release from the sarcoplasmic
reticulum in animal models and humans. Since flecainide exhibits much
lower antiarrhythmic potency in isolated cells and single RyR2 in vitro
than in vivo, whether RyR2 block contributes to its antiarrhythmic
mechanism of action has remained controversial. Here we test the hypothesis
that loss of Calmodulin (CaM), a physiological binding partner of RyR2 Ca
release channels, is responsible for the discrepancy of in vivo and in vitro
results.
Using single channels isolated from sheep hearts and incorporated into lipid
bilayers, we constructed concentration-response curves of flecainide in the
presence and absence of physiological CaM concentrations (100nM). Pres-
ence of CaM potentiated the action of flecainide on single RyR2 channels,
with 3-fold increase in potency (IC50 flecainide¼ 8.6 mM vs. IC50 flecainide
þ CaM¼ 2.8 mM) and a modest increase in Emax. We next tested flecainide
in permeabilized ventricular myocytes isolated from calsequestrin knockout
mice, an established genetic model of Ca-release triggered ventricular
arrhythmia, and from C57Bl6 wild-type mice. Addition of 100 nM CaM
doubled both the potency (from 3 mM to 1.4 mM) and efficacy (from 40%
to 80% inhibition) of Ca wave suppression by flecainide in calsequestrin
KO cells. Moreover, in wild type cells, flecainide had no effect in absence
of CaM, whereas in the presence of CaM, flecainide exhibited a modest effect
in waves suppression with 25% inhibition of Ca waves and IC50 ¼ 1 mM.
Thus, the presence of physiological concentrations of Calmodulin is critical
for flecainide’s block of RyR2 channels and therefore its antiarrhythmic
effect.Excitation-Contraction Coupling I
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Anthracyclines are highly effective chemotherapeutic agents whose use is
limited due to the onset of side effects including potentially fatal cardiotoxic-
ity. The exact molecular mechanism(s) of the cardiotoxicity are unknown,
although two prominent hypotheses involve oxidative stress-mediated cell
damage due to reactive oxygen species (ROS) production, and
anthracycline-induced dysfunction of cardiomyocyte calcium signaling path-
ways. Our previous data has illustrated that the anthracycline doxorubicin
modifies RyR2 and SERCA2A activity by binding to the proteins and also
via thiol oxidation to disrupt SR calcium handling. Calsequestrin (CSQ2), a
calcium binding protein and RyR2 regulator, has been identified as a third
drug-binding target. Our overall aims were to further explore doxorubicin-
induced ROS production and assess any functional consequences of doxoru-
bicin binding to CSQ2.
Firstly, we investigated whether in vitro anthracycline treatment generated the
endogenous ROS superoxide. We used cardiomyocytes from mitochondria-
targeted cpYFP transgenic mice to assess stochastic and quantal bursts of
superoxide produced within the mitochondria matrix (superoxide flashes).
Our results show that increasing doxorubicin concentration from nM to low
uM induces a concentration and time-dependent increase in superoxide flash
frequency and amplitude, indicating that superoxide flash activity contributes
to doxorubicin-induced ROS production.
Secondly, we explored the effects of doxorubicin on CSQ2. Acute doxorubicin
treatment resulted in dissociation of CSQ2 from RyR2. In addition, doxorubicin
binding to RyR2 and CSQ2 disrupted RyR2 responsiveness to the range of
luminal calcium experienced in a cell cycle. Both mechanisms would result
in dysregulated RyR2 calcium release.
Taken together, this data extends our knowledge of the complexity of
doxorubicin-induced cardiomyocyte damage. We propose that doxorubicin
alters calcium homeostasis by targeting RyR2, SERCA2A and CSQ2 directly,
by inducing thiol modification on RyR2 and SERCA2A and by producing
mitochondrial superoxide, all which could contribute to the often-fatal cardi-
otoxicity.1339-Pos Board B290
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The sarcolemmal Naþ/Ca2þ exchanger (NCX) is the primary mechanism for
extruding cytosolic Ca2þ and maintaining Ca2þ homeostasis in cardiomyo-
cytes. NCX activity is allosterically regulated by intracellular Ca2þ concentra-
tion ([Ca2þ]i) via NCX Ca
2þ-binding domains (CBD12). The kinetic and
equilibrium binding properties of CBD12 and the dynamics of NCX activation
have been intensively studied and characterized in Ca2þ binding assays and gi-
ant excised patch voltage clamp experiments. The physiological role of NCX
and the dynamics of its regulation by [Ca2þ]i in intact cardiomyocytes remains
poorly understood. Many previous mathematical models have been formulated
to describe NCX kinetics and its Ca2þ-dependent regulation. However, these
models lack a description of the dynamics of Ca2þ-dependent allosteric regu-
lation. Here we develop a new mechanistic NCX model which incorporates
physiological Ca2þ-binding of CBD12 and predicts features of the time-
dependent regulation of NCX function. We show that NCX activation occurs
slowly (~ seconds) in response to a moderate step increase of [Ca2þ]i
(< 1mM),but exhibits nearly instantaneous activation followed by a slower, sec-
ondary phase in response to a [Ca2þ]i step increase of larger magnitude
(> 1mM). This property enables NCX to differentially sense and respond to dy-
namic Ca2þ signals within specific subcellular compartments in cardiac myo-
cytes (e.g. dyadic cleft, submembrane space, bulk cytosol) and may play an
important role in the regulation of excitation-contraction coupling under both
physiological and pathological conditions. We incorporate this mechanistic
NCX model into a stochastic, local control model of the canine ventricular my-
ocyte and show that over-expression of NCX can be an independent proarrhyth-
mic factor that leads to generation of early-afterdepolarizations.
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Membrane ionic currents (Im)measurement from cardiac multicellular prepara-
tions has been an obstacle in the understanding of cardiac excitability. The role
of Na-Ca exchanger (NCX) in excitation-contraction coupling has remained
elusive greatly due to this difficulty. Here we used loose patch photolysis to
measure Im in intact-perfused whole hearts, to investigate the impact of the
Ca2þ released from the sarcoplasmic reticulum (SR) on the epicardial action
potential (AP). We had previously observed that the epicardial mouse AP, ex-
hibits a phase 2 that is reduced by ryanodine (Ry) and thapsigargin (Tg). To
investigate if Im is directly activated by the SR Ca
2þ release during the phase
2, nifedipine photolysis was used. We found a late-inward current (Ilate) that
was abolished by Ry and Tg. To determine if the NCX was responsible for Ilate,
the NCX blocker SEA0400 was used. SEA0400 had a similar effect on AP
phase 2 as that observed with Ry and Tg. To further test if the SEA0400 effect
was the result of impairing the Ca2þ removal, intracellular Ca2þ transients were
studied. Consistent with NCX blockade, SEA0400 increased the amplitude of
the Ca2þ transients. In addition, to determine if NCX current can be activated
during diastole, intracellular NP-EGTA was photolyzed to activate a Ca2þ
dependent conductance. Our results revealed a diastolic inward current that
increased with the photolysis extent and that was partially blocked by
SEA0400. Our data demonstrate that during an epicardial AP there is a late
influx of Naþ mediated by Ca2þ activation of NCX and that this exchanger,
can also be activated by Ca2þ during diastole. This finding is relevant because
the Ca2þ activation of this transporter is likely to be involved in the genesis of
pro-arrhythmogenic conditions.
1341-Pos Board B292
Structural and Functional Impact of Amino Acid Substitution on Calmod-
ulin Binding in Cardiac Myocytes
Matthew D. McCoy1, Saleet Jafri2, Iosif Vaisman1.
1Bioinformatics and Computational Biology, George Mason University,
Fairfax, VA, USA, 2Molecular Neuroscience, George Mason University,
Fairfax, VA, USA.
Calmodulin (CALM) is an important protein involved in numerous signaling
processes, acting through induced conformational changes in response to local
